79
Participants
Start Date
May 20, 2019
Primary Completion Date
August 2, 2019
Study Completion Date
August 2, 2019
High-flow oxygen therapy (HFOT)
HFOT will be applied by a dedicated large bore nasal cannula (Optiflow+, Fisher\&Paykel, New Zealand) at a flow rate 60 L/min, FiO2 45%, temperature 32 °C, using a HFOT device (myAIRVO2, Fisher\&Paykel, New Zealand).
Low-flow oxygen therapy (LFOT)
LFOT will be provided by a standard nasal cannula at a flow rate of 3 L/min using an oxygen concentrator (EverFlow, Philips Respironics).
National Center of Cardiology and Internal Medicine, Bishkek
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
OTHER_GOV
University of Zurich
OTHER